• Contact Information
• Professional Information
• Research Overview

Dr. Miller is currently a George and Winifred Clark professor at the University of Notre Dame. He is also the Program Director of the Notre Dame Chemistry-Biology-Biochemistry-Interface (CBBI) Training Program.

Education:

Professional:

• 1977-1982 Assistant Professor of Chemistry, University of Notre Dame
• 1982-1986 Associate Professor of Chemistry, University of Notre Dame
• 1986-1996 Professor of Chemistry & Biochemistry, University of Notre Dame
• 1996-present George and Winifred Clark Professor, University of Notre Dame
• 2003-2005 Chairman, Department of Chemistry and Biochemistry, University of Notre Dame
• 2007-present Program Director, Chemistry-Biology-Biochemistry-Interface (CBBI) Training Program, University of Notre Dame

Selected Awards and Honors:

Memberships:

Dr. Miller's research program is internationally recognized as a leader in the design, synthesis and study of new antibiotics, especially beta- lactams, siderophores (microbial iron chelators) and conjugates. His research is centered on the development of new methodology and its incorporation into the synthesis and study of biologically important compounds. Special emphasis is given to asymmetric syntheses and studies of hydroxamic acid containing microbial iron transport agents (siderophores), amino acids, peptides, beta-lactam antibiotics, novel antifungal agents, potential antimalarial agents, carbocyclic analogs of antifungal and anticancer nucleosides and MRI (Magnetic Resonance Imaging) contrast agents. Development and applicatrion of new synthetic methodolody is an important part of the Miller group reserach program. Recently emphasis has included studies of acynitroso cycloaddition for asymmetric syntheses of a variety of biologically interesting compounds that targets several important therapeutic areas. For a more detailed description of Miller group research, please visit the Research webpage.